ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Atherosclerosis"

  • Abstract Number: 1770 • 2016 ACR/ARHP Annual Meeting

    The Impact of Comorbidities on Quality of Life in Systemic Lupus Erythematosus in the First 10 Years

    Murray Urowitz1, Dafna D Gladman2, Nicole Anderson3, Jiandong Su4 and The Systemic Lupus International Collaborating Clinics (SLICC) Group , 1Medicine, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 4Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada

    The Impact of Comorbidities on Quality of Life in Systemic Lupus Erythematosus in the first 10 years   Background/Purpose: The Medical Outcome Survey Short Form…
  • Abstract Number: 1786 • 2016 ACR/ARHP Annual Meeting

    Long-Term Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus in a Large Case Control Cohort Study

    Konstantinos Tselios1, Dafna D Gladman2, Jiandong Su3, Olga Ace4 and Murray Urowitz5, 1Medicine, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 4University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 5Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose:  Certain traditional and disease-related factors have been identified to accelerate atherosclerosis in systemic lupus erythematosus (SLE). Due to the lack of long-term prospective studies,…
  • Abstract Number: 1790 • 2016 ACR/ARHP Annual Meeting

    Accrual of Disease Comorbidities over 8 Years in a Multicentre Inception SLE Cohort

    Murray Urowitz1, Dafna D Gladman2, Nicole Anderson3, Jiandong Su4 and The Systemic Lupus International Collaborating Clinics (SLICC) Group, 1Medicine, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 4Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada

    Background/Purpose: The annual accrual of comorbidities in patients with SLE is not well described.  We report the annual occurrence of these features in an inception…
  • Abstract Number: 738 • 2016 ACR/ARHP Annual Meeting

    Preventive Effect of Combined Treatment with Bisphosphonate and Vitamin D on Atherosclerosis in Patients with Systemic Lupus Erythematosus

    Kazumasa Ohmura, Masaru Kato, Toshiyuki Watanabe, Ryo Hisada, Masatoshi Kanda, Sanae Shimamura, Ikuma Nakagawa, Yuka Shimizu, Kenji Oku, Toshiyuki Bohgaki, Olga Amengual, Tetsuya Horita, Shinsuke Yasuda and Tatsuya Atsumi, Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan

    Background/Purpose: Premature atherosclerosis is one of the major complications of systemic lupus erythematosus (SLE). Preventing atherosclerosis is a key objective while monitoring patients with SLE.…
  • Abstract Number: 2168 • 2016 ACR/ARHP Annual Meeting

    Metabolic Syndrome, All Cause Mortality and Atherosclerotic Cardiovascular Disease in Rheumatic Diseases

    Marco Antivalle1,2, Valentina Varisco2, Alessandra Mutti2, Alberto Batticciotto2, Maria Chiara Ditto2, Fabiola Atzeni3 and Piercarlo Sarzi-Puttini2, 1Rheumatology, Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy, 2Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milan, Italy, 3Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy

    Background/Purpose:  all-cause and cardiovascular mortality and cardiovascular morbidity are reportedly increased in rheumatic diseases, both inflammatory and non-inflammatory. Few studies, however have addressed the impact…
  • Abstract Number: 880 • 2016 ACR/ARHP Annual Meeting

    Pilot Study of Microbubble Contrast-Enhanced Vascular Ultrasonography: A Novel Method of Detecting Large Vessel Vasculitis?

    Kimberly P. Liang1, Douglas P. Landsittel2, Bernadette B. Sendon3, Donald M. Jones4, Suresh R. Mulukutla5, Steven E. Reis6, Ali Hakim Shoushtari7 and Larry W. Moreland8, 1Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 2Medicine, University of Pittsburgh, Pittsburgh, PA, 3Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 4Rheumatology & Clinical Immunology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, 5Division of Cardiology, University of Pittsburgh, Pittsburgh, PA, 6Division of Cardiology and Department of Clinical and Translational Science, University of Pittsburgh, Pittsburgh, PA, 7Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, 8Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose:   A key unmet need in the monitoring of disease activity in large vessel vasculitides (LVV), i.e., giant cell arteritis (GCA) and Takayasu arteritis…
  • Abstract Number: 2425 • 2016 ACR/ARHP Annual Meeting

    The Vasculopathy of Juvenile Dermatomyositis (JDM); Evidence of Persistent Endothelial Injury, Hypercoagulability, Subclinical Inflammation and Increased Arterial Stiffness

    Charalampia Papadopoulou1,2, Ying Hong1, Petra Krol1,2, Yiannis Ioannou3, Clarissa Pilkington2,4,5, Hema Chaplin6, Stephanie Simou1, Marietta Charakida7, Lucy R Wedderburn5,8,9, Paul Brogan10 and Despina Eleftheriou1,8,11, 1Infection, Inflammation and Rheumatology, UCL Institute of Child Health, London, United Kingdom, 2Paediatric Rheumatology, Great Ormond Street Hospital NHS Trust, London, United Kingdom, 3Rayne Institute, Arthritis Research UK Centre for Adolescent Rheumatology, UCL Division of Medicine, London, United Kingdom, 4Paediatric Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, 5Infection, Inflammation and Rheumatology Section, UCL Institute of Child Health, London, United Kingdom, 6Centre for Adolescent Rheumatology, Arthritis Research UK, London, United Kingdom, 7Vascular Physiology Unit, Institute of Cardiovascular Science , University College London, London, United Kingdom, 8Paediatric Rheumatology Department, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, 9Rheumatology Unit, Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, United Kingdom, 10Department of Paediatric Rheumatology, UCL Institute of Child Health and Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom, 11Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, United Kingdom

    Background/Purpose:  Vasculopathy is considered central to the pathogenesis of Juvenile Dermatomyositis (JDM). The interplay between persistent JDM-vasculopathy, traditional cardiovascular risk factors, exposure to corticosteroids, and…
  • Abstract Number: 1178 • 2016 ACR/ARHP Annual Meeting

    Is Subclinical Atherosclerosis Prevalent in a French Patient Cohort with Systemic Lupus Erythematosus?

    Tess Van Meerhaeghe1, Alexis Mathian1, Matthieu Wargny1, Miguel HIe1, Micheline Pha1, Julien Haroche2, Fleur Cohen1, Thi-Huang Du Boutin1 and Zahir Amoura1, 1Department of Internal Medicine 2. Referal center for SLE/APS, Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France, 2Internal Medicine 2. Referal center for SLE/APS, Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France

    Background/Purpose: Systemic lupus erythematosus (SLE) seems associated with an increased risk of cardiovascular disease. These data are mainly based on studies mostly from North America.…
  • Abstract Number: 2463 • 2016 ACR/ARHP Annual Meeting

    Association Between High Sodium Intake and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis

    Gulsen Ozen1, Ali Ugur Unal2, Simge Saydam3, Murat Sunbul4, Kursat Tigen4, Haner Direskeneli5 and Nevsun Inanc1, 1Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey, 2Marmara University, School of Medicine, Rheumatology, Istanbul, Turkey, 3Marmara University Faculty of Medicine, Istanbul, Turkey, 4Department of Cardiology, Marmara University Faculty of Medicine, Istanbul, Turkey, 5Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey

    Background/Purpose: High sodium intake has been reported to be associated with increased ACPA positivity in smoker RA patients. However, apart from this, the associations with…
  • Abstract Number: 1465 • 2016 ACR/ARHP Annual Meeting

    Utility of Relative Cardiovascular Risk Score Scales in Patients UNDER the Age of 50 and Its Association with the Presence of Carotid Atherosclerosis in the Ultrasound

    Andrea Zacarias1, Carmen Gomez Vaquero2, Francisco Javier Narváez3, Miguel Angel González-Gay4, Alfonso Corrales5, Carlos González-Juanatey6, Javier Llorca7 and Joan Miquel Nolla8, 1Hospital Universitari de Bellvitge, Barcelona, Spain, 2Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 3Rheumatology, Hospital Universitario de Bellvitge-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain, 4Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, Santander, Spain, 5Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 6Cardiology Division, Hospital Xeral-Calde, Lugo, Spain, 7Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain, 8Rheumatology, Bellvitge University Hospital, Barcelona, Spain

    Background/Purpose: Rheumatoid Arthritis (RA) is associated with a greater cardiovascular mortality than the general population of the same age and gender. Cardiovascular events prediction scales,…
  • Abstract Number: 2781 • 2016 ACR/ARHP Annual Meeting

    Immunization with ApoB100 Peptide Vaccine Reduces Atherosclerosis Development in a Mouse Model of Systemic Lupus Erythematosus

    Ingrid Yao-Mattisson, Maria Wigren, Gunilla Nordin Fredrikson and Jan Nilsson, Lund University, Malmö, Sweden

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by impaired self-tolerance causing damage to multiple organs including the cardiovascular system. Current therapies do…
  • Abstract Number: 1466 • 2016 ACR/ARHP Annual Meeting

    Cardiovascular Risk Assessment in Persons with Rheumatoid Arthritis: A Correlative Study of Non-Invasive Arterial Health Testing with the Inflammatory Burden of Disease

    Erin Scanlon1, Rekha Mankad2, Cynthia S. Crowson3, Iftikhar Kullo4, Sharon Mulvagh2, Eric L. Matteson1, Zoran Kvrgic1 and John M. Davis III5, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 3Health Sciences Research, Mayo Clinic, Rochester, MN, 4Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose:  Persons with rheumatoid arthritis (RA) have increased morbidity and mortality attributable to atherosclerotic cardiovascular disease (ASCVD) events. It is unknown how presence of subclinical…
  • Abstract Number: 2876 • 2016 ACR/ARHP Annual Meeting

    SLE Serum Impairs NO Production in Huvecs through Induction of eNOS Uncoupling

    Jim Oates1,2, Diane L. Kamen3 and Joy N Jones Buie4, 1Medical Service, Ralph H. Johnson VAMC, Charleston, SC, 2Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, 3Department of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, 4Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Systemic lupus erythematosus (SLE) induces endothelial cell dysfunction (ECD) that can manifest as glomerulonephritis or atherosclerosis. Lupus-prone mice lacking endothelial nitric oxide synthase (eNOS,…
  • Abstract Number: 1467 • 2016 ACR/ARHP Annual Meeting

    Cardiovascular Risk Assessment in Persons with Rheumatoid Arthritis: Non-Invasive Arterial Health Testing to Assess Subclinical Risk of Cardiovascular Disease

    Erin Scanlon1, Rekha Mankad2, Cynthia S. Crowson3, Iftikhar Kullo4, Sharon Mulvagh2, Eric L. Matteson1, Zoran Kvrgic1 and John M. Davis III5, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 3Health Sciences Research, Mayo Clinic, Rochester, MN, 4Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose:   Measures of arterial health may be useful in assessing the risk of atherosclerotic cardiovascular disease (ASCVD) in patients with rheumatoid arthritis (RA). The…
  • Abstract Number: 2880 • 2016 ACR/ARHP Annual Meeting

    Distinct Metabolic Pathways Regulate Lipid Antigen Presentation By Monocytes and B Cells: Implications for SLE Patients with Pre-Clinical Atherosclerotic Plaque

    Kirsty Waddington1, Edward Smith2, Sara Croca3, David A. Isenberg4, Anisur Rahman5, Ines Pineda Torra6 and Elizabeth Jury7, 1Clinical Pharmacology and Rheumatology, University College London, London, United Kingdom, 2Centre for Rheumatology Research, University College London, London, United Kingdom, 3Rheumatology, University College London, London, United Kingdom, 4Centre for Rheumatology Research, University College Hospital London, UK, London, United Kingdom, 5Rayne Institute, Centre for Rheumatology Research, UCL Division of Medicine, London, United Kingdom, 6Clinical Pharmacology, University College London, London, United Kingdom, 7Division of Medicine, Centre for Rheumatology Research, University College London, London, United Kingdom

    Background/Purpose:  Systemic lupus erythematosus (SLE) patients have an increased risk of developing clinically apparent cardiovascular disease (CVD) and subclinical atherosclerotic plaque, detectable by vascular ultrasound…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology